Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.13 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |